Taisho Pharmaceutical Indonesia Tbk.
(IDX: SQBI)

PT Taisho Pharmaceutical Indonesia Tbk is an Indonesia-based pharmaceutical company. The Company's main activity is manufacturing pharmaceutical and health-related products, including over-the-counter products and ethical drugs. The brand names of its over-the-counter products include Counterpain and Tempra; those of its ethical drugs include Kenacort, Kenalog and Mycostatin. The Company’s products are sold in Indonesia, Singapore, Philippines, Thailand and Malaysia. The Company is a part of Taisho Pharmaceutical Co., Ltd., Japan. Its head office is located in Jakarta, Indonesia and its manufacturing plant is located in Depok, Indonesia.

440000.000

- (-%)
Range - - -   (-%)
Open -
Previous Close 440000.000
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume -
Value -
Remark
End-of-day (EOD) prices. Updated for 18 May 2018.
Data powered by
View All Events

About Taisho Pharmaceutical Indonesia Tbk.

PT Taisho Pharmaceutical Indonesia Tbk is an Indonesia-based pharmaceutical company. The Company's main activity is manufacturing pharmaceutical and health-related products, including over-the-counter products and ethical drugs. The brand names of its over-the-counter products include Counterpain and Tempra; those of its ethical drugs include Kenacort, Kenalog and Mycostatin. The Company’s products are sold in Indonesia, Singapore, Philippines, Thailand and Malaysia. The Company is a part of Taisho Pharmaceutical Co., Ltd., Japan. Its head office is located in Jakarta, Indonesia and its manufacturing plant is located in Depok, Indonesia.
Please login to view stock data and analysis